Pantoprazole Apharma

Pantoprazole, the active ingredient in Pantoprazole Apharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and ulcer‑related disorders. GNH USA supplies Pantoprazole Apharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is indicated for several acid‑related gastrointestinal conditions, acting on the gastric proton pump to lower acid output. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: facilitates mucosal repair and symptom relief. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - NSAID‑induced gastric ulcer: aids ulcer healing and prevents recurrence. - Helicobacter pylori eradication (as part of combination therapy): enhances eradication rates by suppressing acid.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea. - Low serum magnesium: muscle cramps or irregular heartbeat. - Vitamin B12 deficiency: fatigue or neuropathy with long‑term use. - Hepatic enzyme elevation: abnormal liver function tests. - Acute pancreatitis: sudden abdominal pain with nausea.

Before initiating therapy, consider the following precautions: - Renal function assessment: adjust use in severe impairment. - Magnesium monitoring: check levels during prolonged treatment. - Liver disease evaluation: use cautiously in hepatic impairment. - Elderly patients: start at the lowest effective dose. - Discontinuation: taper if long‑term use to avoid rebound acid hypersecretion. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture.

Pantoprazole may interact with several medicines, affecting their absorption or metabolism.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption; avoid concurrent use. - Atazanavir: decreased antiviral efficacy; avoid co‑administration. - Clarithromycin: increased risk of cardiac arrhythmia; avoid together.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of anticoagulant effect; monitor INR. - Methotrexate: increased serum levels; check renal function. - Digoxin: reduced absorption; assess serum concentrations.